Clinical trial
Effects on Patient Outcomes With Post-Operative Use of Zynex Neuromuscular Electrical Stimulation (NMES): Zynex-25
NCT07171346 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects on Patient Outcomes With Post-Operative Use of Zynex Neuromuscular Electrical Stimulation (NMES): Zynex-25
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- February 10, 2026
- Completion date
- June 30, 2028
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acl injury, acl reconstruction, acl surgery, electrotherapy, muscle atrophy or weakness